Showing results (381-390 of 645) with videos related to

Sort By:
Pageof 65
Plos One|June 28, 2019
Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registryJoseph A Johnston, David R Nelson, Limin Zhang, et al.
International Journal of Molecular Sciences|July 11, 2020
More P450s Are Involved in Secondary Metabolite Biosynthesis in Streptomyces Compared to Bacillus, Cyanobacteria, and MycobacteriumFanele Cabangile Mnguni, Tiara Padayachee, Wanping Chen, et al.
Physical Biology|April 6, 2012
Selective sweeps in growing microbial coloniesKirill S Korolev, Melanie J I Müller, Nilay Karahan, et al.
BMC Genomics|July 21, 2017
Characterization of the cytochrome P450 monooxygenase genes (P450ome) from the carotenogenic yeast Xanthophyllomyces dendrorhousPamela Córdova, Ana-María Gonzalez, David R Nelson, et al.
Clinical Epidemiology|January 20, 2023
Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims DataJulie Beyrer, David R Nelson, Kristin M Sheffield, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infectionRoniel Cabrera, Zhengkun Tu, Yiling Xu, et al.
International Journal of Molecular Sciences|January 23, 2020
Comprehensive Analyses of Cytochrome P450 Monooxygenases and Secondary Metabolite Biosynthetic Gene Clusters in CyanobacteriaMakhosazana Jabulile Khumalo, Nomfundo Nzuza, Tiara Padayachee, et al.
Genome Announcements|April 9, 2016
Draft Genome Sequence of the New Pathogen for Bivalve Larvae Vibrio bivalvicidaJavier Dubert, Edward J Spinard, David R Nelson, et al.
Plos One|June 23, 2011
Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cellsErika A Eksioglu, Haizhen Zhu, Lilly Bayouth, et al.
Journal of Hepatology|May 2, 2007
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 studyRobert G Gish, Sanjeev Arora, K Rajender Reddy, et al.
Pageof 65